On June 22, 2009, the FDA announced a public comment opportunity on its “Experimental Study of Presentation of Quantitative Effectiveness Information to Consumers in Direct-to-Consumer (DTC) Television and Print Advertisements for Prescription Drugs.” The study will examine: (1) various ways of communicating quantitative efficacy in DTC print ads and (2) whether the findings translate to DTC television ads. Comments will be accepted until August 21, 2009.
Register Now As you are not an existing subscriber please register for your free daily legal newsfeed service.Register
If you have any questions about the service please contact firstname.lastname@example.org or call Lexology Customer Services on +44 20 7234 0606.
FDA comment solicitation on drug advertising
If you are interested in submitting an article to Lexology, please contact Andrew Teague at email@example.com.